Gait Training Using a Wearable Robotic Device for Non-Traumatic Spinal Cord Injury: A Case Report

Introduction: We aimed to report the clinical evaluation results of gait training with the Honda Walking Assist Device ® (HWAT) in a patient with spinal cord injury (SCI). Patients and Methods: A 63-year-old male with SCI (grade D on the American Spinal Injury Association Impairment Scale) underwent...

Full description

Bibliographic Details
Main Authors: Kenichi Yoshikawa PT, PhD, Hirotaka Mutsuzaki MD, PhD, Kazunori Koseki PT, MSc, Yusuke Endo PT, MSc, Yuko Hashizume PT, MSc, Ryo Nakazawa PT, Toshiyuki Aoyama PT, PhD, Arito Yozu MD, PhD, Yutaka Kohno MD, PhD
Format: Article
Language:English
Published: SAGE Publishing 2020-10-01
Series:Geriatric Orthopaedic Surgery & Rehabilitation
Online Access:https://doi.org/10.1177/2151459320956960
Description
Summary:Introduction: We aimed to report the clinical evaluation results of gait training with the Honda Walking Assist Device ® (HWAT) in a patient with spinal cord injury (SCI). Patients and Methods: A 63-year-old male with SCI (grade D on the American Spinal Injury Association Impairment Scale) underwent 20 HWAT sessions over 4 weeks. The self-selected walking speed (SWS), mean step length, cadence, 6-minute walking test (6MWT), Walking Index for SCI score, SCI Functional Ambulation Inventory gait score, American Spinal Injury Association Impairment Scale grade, neurological level, upper and lower extremity motor scores, modified Ashworth Scale, Penn Spasm Frequency Scale, and Spinal Cord Independence Measure version III were measured on admission, at the start of HWAT, at 2 and 4 weeks post-HWAT, and at discharge. Three-dimensional kinematic gait analysis and electromyographic assessments were performed before and after HWAT. Results: The patient safely completed 20 HWAT sessions. We found improvements above the clinically meaningful difference in SWS and 6MWT as well as increased hip extension, ankle plantar- and dorsi-flexion range of motion and increased hip extensor, abductor, adductor, and ankle plantar flexor muscle activity. Discussion: The SWS improved more markedly during the HWAT intervention, exceeding the minimal clinically important difference (0.10 to 0.15 m/s) in walking speed for people with SCI until discharge. Moreover, the 6MWT results at 2 weeks after the start of HWAT exceeded the cutoff value (472.5 m) for community ambulation and remained at a similar value at discharge. Conclusion: The walking distance (6MWT) and the walking speed (SWS) both demonstrated clinically important improvements following 20 treatment sessions which included HWAT.
ISSN:2151-4593